Altrova Health Inc.
SSPLF
$0.03
$0.0010.04%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.55% | -34.26% | -68.99% | -62.04% | -57.94% |
| Depreciation & Amortization | -- | -- | -340.00% | 0.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.50% | -32.30% | -67.97% | -61.91% | -57.95% |
| Operating Income | 9.40% | 33.57% | 68.63% | 62.23% | 57.95% |
| Income Before Tax | -108.16% | -57.33% | 15.87% | 84.43% | 82.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -108.16% | -57.33% | 15.87% | 84.43% | 82.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -108.16% | -57.33% | 15.87% | 84.43% | 82.50% |
| EBIT | 9.40% | 33.57% | 68.63% | 62.23% | 57.95% |
| EBITDA | 10.73% | 34.12% | 68.67% | 47.96% | 32.83% |
| EPS Basic | 1.04% | 27.82% | 60.71% | 90.85% | 86.83% |
| Normalized Basic EPS | 59.50% | 67.11% | 81.88% | 90.60% | 86.53% |
| EPS Diluted | 1.04% | 27.82% | 60.71% | 90.85% | 86.83% |
| Normalized Diluted EPS | 59.50% | 67.11% | 81.88% | 90.60% | 86.53% |
| Average Basic Shares Outstanding | 102.18% | 109.40% | 85.79% | 81.03% | 48.03% |
| Average Diluted Shares Outstanding | 102.18% | 109.40% | 85.79% | 81.03% | 48.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |